BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear. METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively. RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart. CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.
%0 Journal Article
%1 Vasudevan2023-zx
%A Vasudevan, Praveen
%A Wolfien, Markus
%A Lemcke, Heiko
%A Lang, Cajetan Immanuel
%A Skorska, Anna
%A Gaebel, Ralf
%A Galow, Anne-Marie
%A Koczan, Dirk
%A Lindner, Tobias
%A Bergmann, Wendy
%A Mueller-Hilke, Brigitte
%A Vollmar, Brigitte
%A Krause, Bernd Joachim
%A Wolkenhauer, Olaf
%A Steinhoff, Gustav
%A David, Robert
%D 2023
%J Genome Med.
%K Cell Immunocompromised; Machine Macrophages; Myocardial Single-cell infarction; learning; therapy; topic_lifescience
%N 1
%P 61
%T CCR2 macrophage response determines the functional outcome following cardiomyocyte transplantation
%V 15
%X BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear. METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively. RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart. CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.
@article{Vasudevan2023-zx,
abstract = {BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear. METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively. RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart. CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.},
added-at = {2024-09-10T10:41:24.000+0200},
author = {Vasudevan, Praveen and Wolfien, Markus and Lemcke, Heiko and Lang, Cajetan Immanuel and Skorska, Anna and Gaebel, Ralf and Galow, Anne-Marie and Koczan, Dirk and Lindner, Tobias and Bergmann, Wendy and Mueller-Hilke, Brigitte and Vollmar, Brigitte and Krause, Bernd Joachim and Wolkenhauer, Olaf and Steinhoff, Gustav and David, Robert},
biburl = {https://puma.scadsai.uni-leipzig.de/bibtex/224f00e5014ba844d1303b875d8d56e42/scadsfct},
interhash = {6fc044457d368f713da7f774fddd5b93},
intrahash = {24f00e5014ba844d1303b875d8d56e42},
journal = {Genome Med.},
keywords = {Cell Immunocompromised; Machine Macrophages; Myocardial Single-cell infarction; learning; therapy; topic_lifescience},
language = {en},
month = aug,
number = 1,
pages = 61,
timestamp = {2024-09-10T12:00:15.000+0200},
title = {{CCR2} macrophage response determines the functional outcome following cardiomyocyte transplantation},
volume = 15,
year = 2023
}